vTv Therapeutics Inc (VTVT)
27.84
-0.04
(-0.14%)
USD |
NASDAQ |
May 17, 16:00
27.84
0.00 (0.00%)
After-Hours: 20:00
vTv Therapeutics Total Assets (Quarterly): 54.18M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 54.18M |
December 31, 2023 | 11.02M |
September 30, 2023 | 14.92M |
June 30, 2023 | 22.43M |
March 31, 2023 | 28.83M |
December 31, 2022 | 33.24M |
September 30, 2022 | 35.52M |
June 30, 2022 | 36.99M |
March 31, 2022 | 20.18M |
December 31, 2021 | 25.47M |
September 30, 2021 | 31.43M |
June 30, 2021 | 21.66M |
March 31, 2021 | 16.75M |
December 31, 2020 | 14.79M |
September 30, 2020 | 7.046M |
June 30, 2020 | 10.63M |
March 31, 2020 | 7.389M |
December 31, 2019 | 9.266M |
September 30, 2019 | 9.122M |
Date | Value |
---|---|
June 30, 2019 | 9.072M |
March 31, 2019 | 10.74M |
December 31, 2018 | 8.559M |
September 30, 2018 | 11.09M |
June 30, 2018 | 11.23M |
March 31, 2018 | 14.73M |
December 31, 2017 | 27.92M |
September 30, 2017 | 24.06M |
June 30, 2017 | 35.78M |
March 31, 2017 | 48.33M |
December 31, 2016 | 54.50M |
September 30, 2016 | 54.72M |
June 30, 2016 | 66.78M |
March 31, 2016 | 79.56M |
December 31, 2015 | 91.53M |
September 30, 2015 | 100.20M |
June 30, 2015 | 18.97M |
March 31, 2015 | 14.96M |
December 31, 2014 | 12.95M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
7.046M
Minimum
Sep 2020
54.18M
Maximum
Mar 2024
21.00M
Average
18.47M
Median
Total Assets (Quarterly) Benchmarks
Altimmune Inc | 188.36M |
Palatin Technologies Inc | 11.41M |
Oragenics Inc | 4.966M |
Viking Therapeutics Inc | 967.52M |
G1 Therapeutics Inc | 102.03M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 28.20M |
Shareholders Equity (Quarterly) | 20.80M |
Current Ratio | 6.039 |
Net Debt Paydown Yield | 0.08% |